Professor Ward has demonstrated sustained translational and clinical research performance at the highest level. Her research performance is supported through a consistently strong grant track record, including NHMRC and ARC funding, as well as grants from cancer authorities. She has obtained over $38m in competitive funding to support her research activities and has published over 200 articles, books and chapters including in high impact journals such as British Medical Journal, Journal of the National Cancer Institute, Nature Genetics and The New England Journal of Medicine.
As Director of the Translational Cancer Research Centre, Robyn has worked with a network of universities and hospitals to pursue the translational cancer research objectives of the Cancer Institute of NSW. Robyn’s contributions to medical research have been acknowledged through a Commonwealth Health Minister’s Award for Excellence in Health and Medical Research in 2004, the NSW Premier’s Award for Outstanding Cancer Researcher of the Year in 2007, and membership of the Order of Australia, awarded in 2013.
In addition to her clinical and research leadership experience, Robyn has contributed to the development of Commonwealth and NSW health policy, including through her current roles as Chair of the Commonwealth Medical Services Advisory Committee and member of the Pharmaceutical Benefits Advisory Committee. She is currently Co-Chair for Global Genomics Medicine Collaborative (G2MC), which is hosted by the Institute of Medicine of the National Academies in Washington, and seeks to foster global collaboration in demonstrating the real world value of medical genomics to government and industry. Robyn is also on the council of the NHMRC.